140 related articles for article (PubMed ID: 22283654)
1. Development and optimization of controlled release bioerodable anti infective ophthalmic insert.
Thakur R; Swami G; Rahman M
Curr Drug Deliv; 2014; 11(1):2-10. PubMed ID: 22283654
[TBL] [Abstract][Full Text] [Related]
2. Design and in vivo evaluation of carvedilol buccal mucoadhesive patches.
Thimmasetty J; Pandey G; Babu P
Pak J Pharm Sci; 2008 Jul; 21(3):241-8. PubMed ID: 18614419
[TBL] [Abstract][Full Text] [Related]
3. Formulation and development of gastroretentive drug delivery system for ofloxacin.
Ali J; Hasan S; Ali M
Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):433-9. PubMed ID: 17003848
[TBL] [Abstract][Full Text] [Related]
4. Biodegradable ocular inserts for sustained delivery of brimonidine tartarate: preparation and in vitro/in vivo evaluation.
Aburahma MH; Mahmoud AA
AAPS PharmSciTech; 2011 Dec; 12(4):1335-47. PubMed ID: 21979886
[TBL] [Abstract][Full Text] [Related]
5. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of gastroretentive norfloxacin floating tablets.
Bomma R; Swamy Naidu RA; Yamsani MR; Veerabrahma K
Acta Pharm; 2009 Jun; 59(2):211-21. PubMed ID: 19564145
[TBL] [Abstract][Full Text] [Related]
7. Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.
Bhagav P; Upadhyay H; Chandran S
AAPS PharmSciTech; 2011 Dec; 12(4):1087-101. PubMed ID: 21879393
[TBL] [Abstract][Full Text] [Related]
8. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE.
Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA
Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261
[TBL] [Abstract][Full Text] [Related]
9. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
Baviskar D; Sharma R; Jain D
Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of ocular drug delivery system for controlled delivery of gatifloxacin sesquehydrate: In vitro and in vivo evaluation.
Patel UL; Chotai NP; Nagda CD
Pharm Dev Technol; 2012; 17(1):15-22. PubMed ID: 20649410
[TBL] [Abstract][Full Text] [Related]
11. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology.
Kim MS; Kim JS; You YH; Park HJ; Lee S; Park JS; Woo JS; Hwang SJ
Int J Pharm; 2007 Aug; 341(1-2):97-104. PubMed ID: 17499949
[TBL] [Abstract][Full Text] [Related]
12. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation.
Akram M; Naqvi SB; Khan A
Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203
[TBL] [Abstract][Full Text] [Related]
13. Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery.
Ambhore NP; Dandagi PM; Gadad AP
Drug Deliv Transl Res; 2016 Feb; 6(1):48-56. PubMed ID: 26545605
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of mucoadhesive buccal patches of flurbiprofen.
Mishra SK; Garud N; Singh R
Acta Pol Pharm; 2011; 68(6):955-64. PubMed ID: 22125962
[TBL] [Abstract][Full Text] [Related]
15. Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis.
Ferrero C; Massuelle D; Doelker E
J Control Release; 2010 Jan; 141(2):223-33. PubMed ID: 19766681
[TBL] [Abstract][Full Text] [Related]
16. Ocular inserts for controlled delivery of pefloxacin mesylate: preparation and evaluation.
Sultana Y; Aqil M; Ali A
Acta Pharm; 2005 Sep; 55(3):305-14. PubMed ID: 16375841
[TBL] [Abstract][Full Text] [Related]
17. In situ ophthalmic gel of ciprofloxacin hydrochloride for once a day sustained delivery.
Jain SP; Shah SP; Rajadhyaksha NS; Singh P S PP; Amin PD
Drug Dev Ind Pharm; 2008 Apr; 34(4):445-52. PubMed ID: 18401787
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of soluble ocular drug insert for controlled release of ciprofloxacin hydrochloride.
Mundada AS; Shrikhande BK
Drug Dev Ind Pharm; 2006 Apr; 32(4):443-8. PubMed ID: 16638682
[TBL] [Abstract][Full Text] [Related]
19. Formulation and in vitro characterization of ciprofloxacin floating and bioadhesive extended-release tablets.
Varshosaz J; Tavakoli N; Roozbahani F
Drug Deliv; 2006; 13(4):277-85. PubMed ID: 16766469
[TBL] [Abstract][Full Text] [Related]
20. [Optimization of the formulation of ranolazine hydrochloride sustained-release tablet and its pharmacokinetics in dogs].
Li CJ; Yu YL; Yang QM; Li Y; Zhang YH; Wang JY
Yao Xue Xue Bao; 2010 Sep; 45(9):1170-6. PubMed ID: 21351575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
